Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for serious diseases such as oncology and obesity. Its pipeline includes targeted treatments like BCR-ABL inhibitors for chronic myeloid leukemia and oral GLP-1 receptor agonists for weight management. The company emphasizes innovative mechanisms, strategic partnerships, and robust intellectual property to deliver improved clinical outcomes and address unmet medical needs.
This description was generated via AI from an annual report. Updated about 1 year ago.